← Leaderboards
Ana Cecilia Rodriguez
Fundacion Inciensa
$4,601,397
Attributed
$4,601,397
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.3M · FY2012–14$2.5M$1.9M$1.3M$625K$0
'12
'13
'14
Funding mix
By agency
NIH$4,601,397 · 1
By mechanism
N01$4,601,397 · 1
Top collaborators
No co-investigators on record.
Most similar at Fundacion Inciensa
Same institution · by research overlap
- Paula Gonzalez-Maya$38,145,031
- Carolina Porras$11,742,990
- Rolando Herrero$14,003,389
- Paula Gonzalez$28,686,384
- Charles Sanchez$787,124
Others in their field
Top investigators on “Human Papilloma Virus Vaccine”
- Paula Gonzalez-Maya · Fundacion Inciensa$38,145,031
- Paula Gonzalez · Fundacion Inciensa$28,686,384
- Anna R Giuliano · University Of Arizona$20,154,082
- Denise A. Galloway · Fred Hutchinson Cancer Center$13,860,600
- Cosette Marie Wheeler · University Of New Mexico Health Scis Ctr$12,325,400
- Marc Lipsitch · Harvard University (Sch Of Public Hlth)$12,304,512
Research focus
Human Papilloma Virus VaccineHuman Papilloma Virus InfectionAntibodiesHuman Papillomavirus 16AnusCervix UteriBaseCollaborationsCervicalCommunitiesCosta RicaCytologyDoseDrug FormulationsEffectivenessEfficacy EvaluationEnrollmentEvaluationFollow-UpFundingGenetic Crossing OverHigh RiskHuman PapillomavirusImmunogenic
Grant awards (3)
HUMAN PAPILLOMAVIRUS (HPV) TYPE 16 VACCINE TRIAL IN COSTA RICA$325,000
N01 · FY2014 · CA · contact PI
HUMAN PAPILLOMAVIRUS (HPV) TYPE 16 VACCINE TRIAL IN COSTA RICA$2,280,313
N01 · FY2013 · CA · contact PI
HUMAN PAPILLOMAVIRUS (HPV) TYPE 16 VACCINE TRIAL IN COSTA RICA$1,996,084
N01 · FY2012 · CA · contact PI